Progressive multifocal leukoencephalopathy after natalizumab discontinuation: few and true?

Ann Neurol. 2014 Mar;75(3):462. doi: 10.1002/ana.24110. Epub 2014 Mar 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adverse Drug Reaction Reporting Systems / trends*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Female
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Withholding Treatment / trends*

Substances

  • Antibodies, Monoclonal, Humanized